Embolotherapy Market SWOT and PEST Analysis 2021-2031
栓塞治疗市场规模预计将从 2023 年的 38.8 亿美元增至 2031 年的 73.7 亿美元。预计 2023-2031 年市场复合年增长率为 8.3%。增加液体栓塞剂的使用可能仍然是市场的一个主要趋势。
栓塞治疗市场分析
在欧洲地区和世界范围内,中风和动脉瘤的发病率不断上升。例如,在西班牙,中风被认为是继阿尔茨海默病和缺血性心脏病之后的第三大死因。此外,在非洲,高血压是中风的主要危险因素,其他危险因素包括肥胖、压力、吸烟、饮酒、缺乏运动和不健康饮食。此外,2020年南非新诊断出111,321例癌症病例,该国癌症相关死亡人数超过64,547人。由于上述因素,许多组织正在开展旨在降低慢性病死亡率的计划。例如,阿斯利康启动了非洲健康心脏(HHA)计划,以预防高血压并减轻整个非洲日益增加的心血管疾病负担。
栓塞治疗市场概况
越来越多地采用栓塞疗法治疗血管内疾病、创伤性损伤、脑血管畸形、静脉畸形、动静脉畸形和儿科血管疾病,预计将为未来几年栓塞疗法市场收入增长提供机会。加拿大脑动脉瘤的患病率正在上升。根据脑动脉瘤基金会的数据,每年约有 2,800-3,500 人患有脑动脉瘤,约占所有出血性中风的 3%。此外,40岁以上的人群中也存在这种现象。根据加拿大健康信息研究所的数据,未来20年,65岁的人口预计将增长68%。根据脑损伤协会的数据,每年约有 160,000 名加拿大人遭受后天性脑损伤。这些比率继续上升,并可能增加动脉瘤的风险。
定制研究以满足您的要求
我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
栓塞治疗市场:
Embolotherapy Market: Strategic Insights
Embolotherapy Market
-
CAGR (2023 - 2031)
8.3%
-
Market Size 2023
US$ 3.88 Billion
-
Market Size 2031
US$ 7.37 Billion
Key Players
- Abbott Laboratories
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson Johnson Consumer Inc
- Medtronic
- Acandis GmbH
- Terumo Corporation
- Balt USA LLC
- Stryker Corporation
- Guerbet LLC
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
产品(栓塞剂及支持装置)
疾病适应症(癌症,周围血管疾病,神经系统疾病,泌尿及肾脏疾病,胃肠道疾病,其他)
程序(经导管动脉栓塞术
- TAE、经导管动脉放射栓塞术
最终用户(医院和诊所、门诊手术中心、其他最终用户)
Embolotherapy Market: Strategic Insights
-
CAGR (2023 - 2031)8.3% -
Market Size 2023
US$ 3.88 Billion -
Market Size 2031
US$ 7.37 Billion
Key Players
- Abbott Laboratories
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson Johnson Consumer Inc
- Medtronic
- Acandis GmbH
- Terumo Corporation
- Balt USA LLC
- Stryker Corporation
- Guerbet LLC
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
- TAE、经导管动脉放射栓塞术
年均复合增长率(2023 - 2031)8.3%- 2023 年市场规模
38.8 亿美元 - 2031 年市场规模
73.7 亿美元
市场动态
- 患者对微创手术的偏好不断上升,有利于市场
- 栓塞疗法的应用不断增长
- 研发活动数量不断增加
关键人物;主力;重要一员
- 雅培实验室
- 波士顿科学公司
- 库克医疗有限责任公司
- 强生消费品公司
- 美敦力
- 阿坎迪斯有限公司
- 泰尔茂株式会社
- 巴尔特美国有限责任公司
- 史赛克公司
- 加伯特有限责任公司。
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 栓塞剂和支持装置
- 癌症
- 周边血管疾病
- 神经系统疾病
- 泌尿及肾病
- 胃肠道疾病
- 其他
- 经导管动脉栓塞术
- 医院及诊所
- 日间手术中心
- 其他最终用户
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
栓塞治疗市场驱动因素和机遇
患者对微创手术的偏好不断上升,有利于市场
人们的偏好已从开放式手术转向具有实时成像的微创手术。前列腺动脉栓塞(PAE)也是一种微创疗法,作为选择性门诊技术实施,用于治疗良性前列腺增生(BPH)继发的下尿路症状(LUTS)。近年来,PAE 治愈的患者总数有所增加。栓塞已成为一种实现血管闭塞的微创技术。液体栓塞剂引起了相当大的关注,因为它们深入血管并且独立于血栓形成,而血栓形成依赖于患者的凝血系统。
研发活动数量不断增加
由于研发活动不断增加,新的引进和创新预计将推动新技术的采用,推动市场增长。例如,2021年9月,韩国食品药品安全部(MFDS)批准了微创神经科技的NUMEN弹簧圈栓塞系统和NUMEN FR脱离系统。对于医院用途,由于其稳定的栓塞和致密的堆积,NUMEN 主要用于血管内弹簧圈栓塞手术,以治疗颅内动脉瘤。此外,他们还自主开发了NUMEN线圈栓塞系统,该系统被韩国健康保险审查和评估院(HIRA)批准为符合韩国健康保险报销资格的产品。上述因素可能会在预测期内为栓塞治疗市场创造机会。
栓塞治疗市场报告细分分析
有助于栓塞治疗市场分析的关键部分是产品、疾病适应症、手术和最终用户。
- 根据产品,栓塞治疗市场分为栓塞剂和支持设备。此外,栓塞剂的部分被细分为微球、栓塞线圈、液体栓塞剂、栓塞系统、可拆卸球囊等。此外,支撑装置部分进一步分为微导管和导丝。 2023 年,栓塞剂细分市场占据更大的市场份额。
- 根据疾病适应症,栓塞治疗市场分为癌症、周围血管疾病、神经系统疾病、泌尿和肾病、胃肠道疾病等。到 2023 年,癌症细分市场将占据更大的市场份额。
- 根据手术方式,栓塞治疗市场分为经导管动脉栓塞(TAE)、经导管动脉放射栓塞(TARE)/选择性体内放射治疗(SIRT)和经动脉化疗栓塞(TACE)。 2023 年,经导管动脉栓塞 (TAE) 细分市场占据更大的市场份额。
- 根据最终用户,栓塞治疗市场分为医院和诊所、门诊手术中心和其他最终用户。 2023 年,医院和诊所细分市场占据更大的市场份额。
按地域划分的栓塞治疗市场份额分析
栓塞疗法市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲和中美洲。
北美市场占据主导地位,预计亚太地区未来几年将以最高的复合年增长率增长。亚太市场的增长归因于脑中风、冠状动脉疾病、心脏病的患病率上升、外科手术的增加等。由于胆固醇、血压、吸烟和糖尿病等危险因素的增加,心血管疾病的发病率不断上升。日本男性吸烟率为 35.4%,高于美国男性吸烟率。此外,2022年6月,美敦力推出了具有CE标志的第四代分流器,这是一种采用屏蔽技术的Pipeline Vantage栓塞装置,用于脑动脉瘤的血管内治疗。上述因素将推动栓塞治疗市场的发展。
栓塞治疗市场报告范围
报告属性 | 细节 |
---|---|
2023年市场规模 | 38.8亿美元 |
2031 年市场规模 | 73.7亿美元 |
全球复合年增长率(2023 - 2031) | 8.3% |
历史数据 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的细分市场 | 按产品分类
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
栓塞治疗市场新闻和最新动态
通过收集初级和二级研究后的定性和定量数据来评估栓塞疗法市场,其中包括重要的公司出版物、协会数据和数据库。下面列出了栓塞治疗市场的一些发展:
- Terumo Medical Corporation 宣布在美国推出新型 AZUR HydroPack 外围线圈系统。该线圈旨在寻找并填充血管内的空间,并且它是唯一使用专有水凝胶技术来创建用于机械闭塞的凝胶核心的填充线圈。 (来源:Terumo Medical Corporation,新闻稿,2023 年 12 月)
- 加柏宣布将其微导管产品线增加一倍,并推出新的导丝产品线,从而提供广泛的介入成像和栓塞解决方案。 (来源:加柏,新闻稿,2022 年 3 月)
栓塞治疗市场报告范围和交付成果
《栓塞疗法市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:
- 该范围内所有关键细分市场的栓塞治疗市场规模以及全球、区域和国家层面的预测
- 栓塞治疗市场趋势以及市场动态,例如驱动因素、限制因素和关键机会
- 详细的 PEST/波特五力分析和 SWOT 分析
- 栓塞治疗市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展3
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及栓塞治疗市场的最新发展
- 详细的公司简介
Embolotherapy Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 3.88 Billion |
Market Size by | US$ 7.37 Billion |
Global CAGR | 8.3% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By 产品(栓塞剂及支持装置)
|
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America has dominated the Embolotherapy market.
Factors such as rising patient preference for minimally invasive procedures and growing application of embolotherapy will boost the market growth.
Increasing use of liquid embolic agents is likely to remain a key trend in the market.
The Embolotherapy market size is projected to reach US$ 7.37 billion by 2031.
The market is expected to register a CAGR of 8.3% during 2023–2031.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.